US2016185766A1PendingUtilityA1
Novel Salts of Raltegravir
Est. expiryApr 6, 2031(~4.7 yrs left)· nominal 20-yr term from priority
Inventors:Purna Chandra RayAshok Sopanrao YadavDnyaneshwar Tukaram SingareSurinder Kumar AroraGirij Pal Singh
C07D 413/12A61K 31/513C07C 211/04A61P 31/12
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are novel salts of raltegravir, viz., meglumine salt, erbumine salt, ammonium salt, tris salt and L-arginine salt of raltegravir and processes for their preparation.
Claims
exact text as granted — not AI-modified1 . An Erbumine salt of raltegravir.
2 . A crystalline erbumine salt of raltegravir, represented by formula II,
which is characterized by XRPD (X-ray powder diffractogram) comprising of peaks expressed as 2θ at 4.2, 8.4, 9.1, 11.7, 12.6, 13.8, 15.2, 16.9, 18.0, 18.4, 18.8, 19.0, 20.8, 21.2, 22.0, 22.4 and 22.7±0.2 degrees.
3 . A process for preparation of crystalline erbumine salt of raltegravir of claim 2 , which comprises treating raltegravir with tert-butyl amine in an alcohol.
4 . The process according to claim 3 , wherein the alcohol is selected from methanol, ethanol, n-propanol and isopropanol.
5 . The process according to claim 4 , wherein the alcohol is methanol.
6 . The process according to claim 3 , wherein the molar ratio of tertiary butyl amine with respect to raltegravir is in the range of 1 to 3.Join the waitlist — get patent alerts
Track US2016185766A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.